| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Director | Chief Executive Officer
2 companies
Winningham Rick E is a Chief Executive Officer at Theravance Biopharma, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 1 buy and 13 sells.
Estimated insider holdings value: $30.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2025 | JAZZ Jazz Pharmaceuticals Plc | Director | Sell | 5,500 | $180.86 | $994,728.35 | -38.2% | -6.9% | - | |
| Aug 14, 2023 | JAZZ Jazz Pharmaceuticals Plc | Director | Sell | 1,241 | $138.16 | $171,454.57 | -10.6% | -12.9% | -20.2% | |
| Dec 14, 2022 | TBPH Theravance Biopharma, Inc. | Chief Executive Officer | Sell | 50,000 | $11.19 | $559,500.00 | -3.6% | -5.4% | -1.8% | |
| Aug 8, 2022 | JAZZ Jazz Pharmaceuticals Plc | Director | Sell | 1,089 | $152.32 | $165,879.31 | -11.2% | -5.7% | -14.2% | |
| Aug 6, 2021 | JAZZ Jazz Pharmaceuticals Plc | Director | Sell | 1,306 | $147.96 | $193,235.76 | -15.5% | -11.0% | +2.5% | |
| Aug 7, 2020 | JAZZ Jazz Pharmaceuticals Plc | Director | Sell | 931 | $125.87 | $117,184.88 | -13.1% | - | - | |
| Aug 9, 2019 | JAZZ Jazz Pharmaceuticals Plc | Director | Sell | 726 | $135.65 | $98,482.19 | -14.1% | - | - | |
| Aug 10, 2018 | JAZZ Jazz Pharmaceuticals Plc | Director | Sale+OE | 16,639 | $176.18 | $2,931,400.75 | -35.1% | - | - | |
| Aug 11, 2017 | TBPH Theravance Biopharma, Inc. | Chief Executive Officer | Buy | 10,000 | $24.50 | $245,000.00 | +1.2% | - | - | |
| Aug 11, 2017 | JAZZ Jazz Pharmaceuticals Plc | Director | Sell | 662 | $142.37 | $94,247.89 | -2.9% | - | - |